Hepatitis B virus and hepatocellular carcinoma

Area of Science:

• Hepatology
• Oncology
• Virology

Background:

• Chronic hepatitis B virus (HBV) infection is a primary global driver of hepatocellular carcinoma (HCC).
• Chronic HBV carriers face over a 100-fold increased relative risk for developing HCC.
• Multiple mechanisms are implicated in HBV-induced HCC development.

Purpose of the Study:

• To review proposed mechanisms of HBV-induced HCC.
• To explore the role of HBV DNA integration, HBx protein functions, and HBV genome variations in hepatocarcinogenesis.
• To discuss the indirect contributions of necroinflammatory liver disease to HCC development.

Main Methods:

• Review of proposed mechanisms for HBV-induced HCC.
• Analysis of HBV DNA integration patterns in hepatocytes.
• Examination of the oncogenic functions of the HBx protein and its cellular interactions.
• Consideration of HBV genome sequence variations and their potential role.
• Assessment of the impact of necroinflammation on hepatocyte transformation.

Main Results:

• HBV DNA integration into the hepatocyte genome is common, but integration at critical regulatory sites is rare.
• The HBx protein exhibits oncogenic functions, including transcriptional activation, apoptosis modulation, and DNA repair inhibition.
• Necroinflammation associated with chronic HBV infection may indirectly promote HCC through various pathways.

Conclusions:

• HBV infection is a major risk factor for HCC, driven by viral DNA integration, HBx protein activity, and host inflammatory responses.
• While HCC has a poor prognosis, HBV vaccination offers a promising strategy for the eventual elimination of HBV-associated HCC.
• Further research is needed to fully elucidate the significance of HBV genome variations in hepatocarcinogenesis.